Thomas J. Shaw Acquires 18,411 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 18,411 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was acquired at an average price of $0.78 per share, for a total transaction of $14,360.58. Following the purchase, the chief executive officer now directly owns 14,947,978 shares in the company, valued at approximately $11,659,422.84. The trade was a 0.12 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

Retractable Technologies Trading Up 9.3 %

NYSE RVP opened at $0.82 on Wednesday. The business’s fifty day moving average is $0.66 and its 200-day moving average is $0.85. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The stock has a market capitalization of $24.40 million, a price-to-earnings ratio of -1.51 and a beta of 1.94. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.34.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on Retractable Technologies in a report on Monday. They set a “hold” rating on the stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.